Table 2.
Name | MIN Score | PPV% (Ya = 0.001) | PPV% (Ya = 0.01) | Structure | Score docking | Current therapeutic indication |
---|---|---|---|---|---|---|
Clomifene | 0.4837 | 14.64 | 63.38 | −9.37 | Used mainly in female infertility due to anovulation | |
Butoconazole | 0.4768 | 14.64 | 63.38 | −9.87 | Local treatment of vulvovaginal candidiasis | |
Meclizine | 0.4546 | 12.30 | 58.61 | −8.95, −6.64a | Motion sickness and vertigo | |
Clemizole hydrochloride | 0.4544 | 12.30 | 58.61 | −8.91 | Allergies | |
Cinnarizine | 0.4273 | 9.20 | 50.56 | −7.43 | Motion sickness and vertigo | |
Centchroman | 0.3798 | 5.67 | 37.76 | −6.31 | Primarily used as a contraceptive | |
Oxiconazole | 0.3751 | 5.00 | 34.68 | −10.44 | Dermal fungal infections. | |
Astemizole | 0.3666 | 4.25 | 30.96 | −6.45 | Allergies | |
Clofazimine | 0.3605 | 4.06 | 29.92 | −1.58 | Leprosy |
The docking scores of both isomers were calculated.